This HTML5 document contains 136 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q40525696
rdf:type
wikibase:Item
schema:description
2004年论文 artikel ilmiah სამეცნიერო სტატია artículu científicu espublizáu en 2004 article scientific teaduslik artikkel научна статия vitskapeleg artikkel tudományos cikk bilimsel makale artigo científico article scientifique 2004年论文 บทความทางวิทยาศาสตร์ 2004年論文 научни чланак artikulong pang-agham scientific article published on January 2004 2004年论文 мақолаи илмӣ מאמר מדעי 2004年論文 vitenskapelig artikkel wetenschappelijk artikel bài báo khoa học articolo scientifico مقالة علمية نشرت في يناير 2004 2004년 논문 tieteellinen artikkeli 2004 nî lūn-bûn научная статья artigo científico vedecký článok scientific article published on January 2004 2004年论文 wissenschaftlicher Artikel 2004年論文 জানুয়ারি ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel 2004年论文 scienca artikolo наукова стаття, опублікована в січні 2004 artículo científico publicado en 2004 2004年論文 artykuł naukowy artigo científico naučni članak επιστημονικό άρθρο научни чланак 2004年の論文 artikull shkencor vetenskaplig artikel articol științific scientific article published on January 2004 vědecký článek 2004年论文 2004年論文 article científic
p:P577
wds:Q40525696-470C6909-1BB5-4ACD-A324-0173D8B87FB9
wdt:P577
2004-01-01T00:00:00Z
p:P2860
wds:Q40525696-800AB2BC-4572-4182-84D2-4853ECA56FD9 wds:Q40525696-8320C792-C337-443A-8E5B-0DEBB17C5D7F wds:Q40525696-C9D3505F-B62C-4B89-A80F-24618320837C wds:Q40525696-CA8DFA69-C88D-41CC-81CA-AAD82F7C01EB wds:Q40525696-B110C75C-3AE1-41CB-B008-ED18583B5402 wds:Q40525696-B967738D-B6D6-4D13-9D49-F70050EFCD34 wds:Q40525696-C7A13963-1D44-4C10-8ADC-4BA2C04E2F2B wds:Q40525696-0708B95E-B6EA-41CA-BE86-8AE14AC12C30 wds:Q40525696-F3A54A82-0C67-4044-8E86-BC44A89A63A1 wds:Q40525696-0937ABF6-7EA5-42A8-A594-077646B722D5 wds:Q40525696-26DC0014-797C-4455-B412-F34C2BCACC2D wds:Q40525696-69AF6E75-AFCD-4047-9CE7-D5AE1A5855ED wds:Q40525696-6FD38BE3-9D52-4CEF-823E-95ED1845A571 wds:Q40525696-4FFC3EFA-A687-418C-B3C0-16ED3C644ACA wds:Q40525696-5322EFAE-1AFD-4E7E-9DDA-B36A9C41BBEC wds:Q40525696-63715617-D509-48DB-9B90-0B44AF1EE4C8 wds:Q40525696-9A9C6CC2-6A72-47EB-81C0-41F8FBCBCBAA wds:Q40525696-AA173200-5B66-4A34-985F-CFF41865A3C7 wds:Q40525696-AE3F67E0-8C81-4AE8-AA4F-368AE8E20ED6 wds:Q40525696-7C8BC901-9873-4FD1-9B3B-78187528A907
wdt:P2860
wd:Q40596475 wd:Q34114674 wd:Q40669038 wd:Q40734999 wd:Q40700987 wd:Q40591496 wd:Q36757158 wd:Q33183428 wd:Q40551416 wd:Q40570367 wd:Q40633806 wd:Q50656633 wd:Q40615385 wd:Q40805848 wd:Q40678015 wd:Q35641123 wd:Q40550138 wd:Q40579442 wd:Q34737387 wd:Q33913964
p:P2093
wds:Q40525696-B106917E-3F98-46FA-A309-F7E04DFB3F51 wds:Q40525696-CAE38319-4CF6-4D1A-8629-FB57FA12F4B4 wds:Q40525696-EB6F0EFC-9D2C-4CF4-A3B9-24F1FCFFB6B6 wds:Q40525696-FBF776AB-4172-4482-9CAB-5DFC434516E4 wds:Q40525696-09069E76-F975-4ABC-9266-7D3EF7C93F80 wds:Q40525696-282801E9-4D7F-47AF-BC74-92869FDEF238
wdt:P2093
Magnus Björkholm Per Engervall Mats Kalin Peter Johansson Robert Hast Honar Cherif
rdfs:label
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
skos:prefLabel
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
schema:name
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
p:P50
wds:Q40525696-733C6721-A9CA-4C9D-ADCA-96C314493681
wdt:P50
wd:Q52717443
p:P1476
wds:Q40525696-2469FDDD-8B19-450F-9ED6-CADB57AA64B7
wdt:P1476
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
p:P304
wds:Q40525696-9605629A-C155-4670-ADD4-ABF78C60C278
wdt:P304
593-600
p:P31
wds:Q40525696-5DACA651-3792-42CA-A3E3-22CBACA3EA5A
wdt:P31
wd:Q13442814
p:P698
wds:Q40525696-743C5FD5-1C7B-4DDA-BEEE-5C51351EFF53
wdtn:P698
n8:15370671
wdt:P698
15370671
p:P1433
wds:Q40525696-315B5A0D-98BF-4AF5-BC83-B6D816E3AD2B
wdt:P1433
wd:Q7429961
p:P433
wds:Q40525696-4C94F322-8E3D-4314-86AF-29155C534C4C
p:P478
wds:Q40525696-2CE5DC8A-1DDD-424F-8159-D68A442405A1
wdt:P433
8
wdt:P478
36
p:P356
wds:Q40525696-7D0E93AD-36A8-4312-A399-0B36C17CA139
wdtn:P356
n11:00365540410017590
wdt:P356
10.1080/00365540410017590